VTYX - Ventyx Biosciences, Inc.
14
0.020 0.143%
Share volume: 5,448,870
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$13.98
0.02
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 02-27-2025 | 05-08-2025 | 11-06-2025 | |
| Cash flow financing | 96.184 M | -906.000 K | 26.862 M | -25.000 K | 0.000 | 203.000 K | |
| Other financing cash flows | 92.000 K | 26.000 K | 12.000 K | 131.000 K | 0.000 | 203.000 K | |
| Cash flow | 90.324 M | -100.964 M | 20.648 M | -34.272 M | 697.000 K | -254.000 K | |
| Net income | -38.572 M | -31.950 M | -35.249 M | -29.351 M | -27.440 M | -22.829 M | |
| Depreciation | 70.000 K | 65.000 K | 66.000 K | 65.000 K | 100.000 K | 58.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 41.765 M | -75.520 M | 29.247 M | -10.998 M | 26.415 M | 17.051 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 175.000 K | 60.000 K | 0.000 | 6.000 K | 16.000 K | 50.000 K | |
| Cash Change | 90.319 M | -100.973 M | 20.840 M | -34.505 M | 816.000 K | -331.000 K |